InvestorsObserver
×
News Home

Where Does Trevi Therapeutics Inc (TRVI) Stock Fall in the Biotechnology Field After It Is Lower By -2.10% This Week?

Friday, June 17, 2022 12:48 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Trevi Therapeutics Inc (TRVI) Stock Fall in the Biotechnology Field After It Is Lower By -2.10% This Week?

Trevi Therapeutics Inc (TRVI) is near the top in its industry group according to InvestorsObserver. TRVI gets an overall rating of 86. That means it scores higher than 86 percent of stocks. Trevi Therapeutics Inc gets a 100 rank in the Biotechnology industry. Biotechnology is number 66 out of 148 industries.

Overall Score - 86
TRVI has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on TRVI!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Trevi Therapeutics Inc Stock Today?

Trevi Therapeutics Inc (TRVI) stock is trading at $2.33 as of 12:43 PM on Friday, Jun 17, a gain of $0.10, or 4.48% from the previous closing price of $2.23. The stock has traded between $2.21 and $2.43 so far today. Volume today is light. So far 52,782 shares have traded compared to average volume of 127,333 shares. Click Here to get the full Stock Report for Trevi Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App